| Market revenue in 2025 | USD 331.4 million |
| Market revenue in 2033 | USD 629.7 million |
| Growth rate | 8.4% (CAGR from 2026 to 2033) |
| Largest segment | Thyroid stimulating hormone (tsh) test |
| Fastest growing segment | Dehydroepiandrosterone Sulfate (DHEAS) Test |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Thyroid Stimulating Hormone (TSH) Test, Insulin Test, Testosterone Test, Cortisol Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Follicle Stimulating Hormone (FSH) Test, Luteinizing Hormone (LH) Test, Estradiol (E2) Test, Progesterone Test, Prolactin Test, Dehydroepiandrosterone Sulfate (DHEAS) Test |
| Key market players worldwide | Abbott Laboratories, Danaher Corp, Agilent Technologies Inc, BioMerieux SA, Bio-Rad Laboratories Inc, Diasorin SpA, Roche Holding AG ADR, Labcorp Holdings Inc, Quest Diagnostics Inc, QuidelOrtho Corp |
Publish Date: May 11, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| QuidelOrtho Corp | View profile | 7,100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | www.quidelortho.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| Diasorin SpA | View profile | 3,233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | www.diasoringroup.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Endocrine Testing Market Outlook will help companies and investors design strategic landscapes.
Thyroid Stimulating Hormone (Tsh) Test was the largest segment with a revenue share of 32.35% in 2025.
Horizon Databook has segmented the Spain endocrine testing market based on thyroid stimulating hormone (tsh) test, insulin test, testosterone test, cortisol test, human chorionic gonadotropin (hcg) hormone test, follicle stimulating hormone (fsh) test, luteinizing hormone (lh) test, estradiol (e2) test, progesterone test, prolactin test, dehydroepiandrosterone sulfate (dheas) test covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain Endocrine Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Spain Endocrine Testing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
